High Mobility Group Box 3 (HMGB3) Peptide
HMGB3
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all HMGB3 products
- HMGB3 (High Mobility Group Box 3 (HMGB3))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-HMGB3 antibody (Catalog #: ARP35765_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- HMGB3 (High Mobility Group Box 3 (HMGB3))
- Background
-
The human HMG2a gene is transcribed mainly in the placenta. HMG2a encodes a protein which is part of the high mobility group (HMG) family. Members of this family are ubiquitously expressed and facilitate the formation of nucleoprotein complexes where the DNA is sharply bent.
Alias Symbols: HMG4, HMG-4, HMG2A, HMG-2a
Protein Size: 200 - Molecular Weight
- 23 kDa
- Gene ID
- 3149
- NCBI Accession
- NM_005342, NP_005333
- UniProt
- O15347
-
You are here:
